Nifty
Sensex
:
:
24457.15
80845.75
181.10 (0.75%)
597.67 (0.74%)

Chemicals

Rating :
N/A

BSE: 530019 | NSE: JUBLPHARMA

1226.65
03-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1212.85
  •  1232.50
  •  1193.10
  •  1202.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  179787
  •  2192.99
  •  1309.90
  •  450.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 19,167.10
  • 32.32
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 20,914.70
  • 0.42%
  • 3.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.60%
  • 18.09%
  • FII
  • DII
  • Others
  • 17.94%
  • 3.70%
  • 5.99%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.41
  • -6.04
  • 3.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.53
  • -14.29
  • -4.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -17.06
  • -38.80
  • -42.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.29
  • 14.31
  • 18.19

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.06
  • 1.69
  • 1.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.53
  • 9.50
  • 10.72

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
4.87
48.1
28.3
47.7
P/E Ratio
233.39
23.63
40.16
23.83
Revenue
6703
7122
7881
8652
EBITDA
901
1179
1428
1711
Net Income
77
767
451
760
ROA
0.7
0.1
0.1
0.1
P/Bk Ratio
3.33
2.95
2.77
2.51
ROE
1.42
13.3
7.1
11
FCFF
-144.4
FCFF Yield
-0.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
1,752.30
1,680.30
4.28%
1,731.70
1,586.90
9.12%
1,758.60
1,678.00
4.80%
1,677.10
1,552.50
8.03%
Expenses
1,462.90
1,438.50
1.70%
1,480.20
1,417.30
4.44%
1,487.20
1,458.80
1.95%
1,459.10
1,406.60
3.73%
EBITDA
289.40
241.80
19.69%
251.50
169.60
48.29%
271.40
219.20
23.81%
218.00
145.90
49.42%
EBIDTM
16.52%
14.39%
14.52%
10.69%
15.43%
13.06%
13.00%
9.40%
Other Income
21.70
9.90
119.19%
14.00
8.60
62.79%
14.40
4.40
227.27%
35.80
9.50
276.84%
Interest
61.00
66.10
-7.72%
71.00
61.90
14.70%
73.00
55.60
31.29%
71.30
50.70
40.63%
Depreciation
91.40
96.60
-5.38%
90.70
89.70
1.11%
101.00
271.20
-62.76%
94.60
94.30
0.32%
PBT
144.50
89.00
62.36%
499.70
26.60
1,778.57%
-57.10
-103.20
-
87.90
10.40
745.19%
Tax
41.90
35.90
16.71%
17.90
19.20
-6.77%
8.10
14.10
-42.55%
34.60
24.80
39.52%
PAT
102.60
53.10
93.22%
481.80
7.40
6,410.81%
-65.20
-117.30
-
53.30
-14.40
-
PATM
5.86%
3.16%
27.82%
0.47%
-3.71%
-6.99%
3.18%
-0.93%
EPS
6.51
3.96
64.39%
30.51
0.41
7,341.46%
-3.71
-6.16
-
4.23
-0.98
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
6,919.70
6,702.90
6,281.70
6,130.16
6,098.53
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
Net Sales Growth
6.49%
6.71%
2.47%
0.52%
-33.38%
0.48%
21.19%
28.26%
1.95%
-1.32%
 
Cost Of Goods Sold
2,179.80
2,140.70
1,877.90
1,488.01
1,536.01
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
Gross Profit
4,739.90
4,562.20
4,403.80
4,642.16
4,562.52
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
GP Margin
68.50%
68.06%
70.11%
75.73%
74.81%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
Total Expenditure
5,889.40
5,802.10
5,505.50
4,973.83
4,702.07
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
Power & Fuel Cost
-
148.90
166.70
134.30
105.79
112.21
466.38
424.91
333.66
366.71
393.04
% Of Sales
-
2.22%
2.65%
2.19%
1.73%
1.23%
5.12%
5.65%
5.69%
6.38%
6.75%
Employee Cost
-
2,216.00
2,166.00
2,043.39
1,922.88
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
% Of Sales
-
33.06%
34.48%
33.33%
31.53%
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
Manufacturing Exp.
-
523.20
581.10
562.32
449.40
362.15
552.26
485.98
428.84
436.46
432.40
% Of Sales
-
7.81%
9.25%
9.17%
7.37%
3.96%
6.06%
6.46%
7.32%
7.59%
7.42%
General & Admin Exp.
-
475.00
464.10
432.34
387.92
416.80
540.75
354.56
280.98
256.23
302.28
% Of Sales
-
7.09%
7.39%
7.05%
6.36%
4.55%
5.94%
4.72%
4.79%
4.46%
5.19%
Selling & Distn. Exp.
-
214.30
161.60
209.71
177.15
194.71
267.70
247.85
185.79
135.54
203.98
% Of Sales
-
3.20%
2.57%
3.42%
2.90%
2.13%
2.94%
3.30%
3.17%
2.36%
3.50%
Miscellaneous Exp.
-
84.00
88.10
103.77
122.93
853.22
96.92
67.76
53.20
65.96
203.98
% Of Sales
-
1.25%
1.40%
1.69%
2.02%
9.32%
1.06%
0.90%
0.91%
1.15%
0.68%
EBITDA
1,030.30
900.80
776.20
1,156.33
1,396.46
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
EBITDA Margin
14.89%
13.44%
12.36%
18.86%
22.90%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
Other Income
85.90
68.70
38.30
11.29
17.64
47.43
35.74
40.03
24.86
13.37
42.45
Interest
276.30
272.30
188.20
145.49
184.10
287.41
219.81
284.28
341.11
371.35
367.61
Depreciation
377.70
381.90
554.00
381.70
348.95
461.93
370.90
415.05
291.40
346.74
287.95
PBT
675.00
315.30
72.30
640.43
881.05
1,245.17
1,184.04
859.08
737.64
542.22
88.43
Tax
102.50
97.80
92.70
217.43
297.22
312.29
326.80
224.66
163.02
155.40
80.48
Tax Rate
15.19%
66.80%
598.06%
33.95%
34.57%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
PAT
572.50
77.10
-61.00
413.94
562.87
898.24
574.46
642.81
575.66
391.83
-57.76
PAT before Minority Interest
576.70
72.70
-64.90
413.02
562.61
898.24
577.01
634.42
574.63
386.82
-40.16
Minority Interest
4.20
4.40
3.90
0.92
0.26
0.00
-2.55
8.39
1.03
5.01
-17.60
PAT Margin
8.27%
1.15%
-0.97%
6.75%
9.23%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
PAT Growth
904.07%
-
-
-26.46%
-37.34%
56.36%
-10.63%
11.66%
46.92%
-
 
EPS
35.94
4.84
-3.83
25.98
35.33
56.39
36.06
40.35
36.14
24.60
-3.63

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
5,433.90
5,399.30
5,318.56
4,741.49
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
Share Capital
15.80
15.90
15.92
15.92
15.93
15.93
15.58
15.57
15.54
15.93
Total Reserves
5,403.60
5,377.20
5,298.98
4,724.75
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
Non-Current Liabilities
4,005.70
3,765.00
2,921.59
2,973.05
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
Secured Loans
299.30
265.10
200.94
20.78
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
Unsecured Loans
2,867.80
2,845.30
2,263.30
2,543.19
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
Long Term Provisions
100.10
92.20
95.67
94.01
150.75
114.35
107.08
80.69
70.31
67.04
Current Liabilities
1,889.00
1,772.40
1,591.60
1,048.83
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
Trade Payables
856.30
821.30
567.74
520.48
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
Other Current Liabilities
732.80
552.10
838.52
371.73
674.21
473.57
505.87
572.70
951.43
793.31
Short Term Borrowings
196.50
258.30
64.00
20.00
649.89
499.71
244.85
255.60
748.97
517.17
Short Term Provisions
103.40
140.70
121.34
136.62
204.64
96.31
117.81
106.24
151.93
97.49
Total Liabilities
11,315.80
10,929.20
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
Net Block
5,091.20
5,183.30
4,870.61
4,608.75
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
Gross Block
7,868.90
7,368.00
6,758.89
6,089.57
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
Accumulated Depreciation
2,777.70
2,184.70
1,888.28
1,480.83
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
Non Current Assets
7,439.70
7,166.80
6,320.40
5,810.90
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
Capital Work in Progress
2,103.10
1,561.50
1,089.57
896.99
768.39
901.43
670.97
683.78
611.32
596.60
Non Current Investment
42.20
256.40
238.60
240.96
69.36
115.11
123.52
102.71
85.43
39.50
Long Term Loans & Adv.
191.90
161.50
117.64
62.84
86.81
68.59
71.79
56.32
62.67
327.17
Other Non Current Assets
11.30
4.10
3.98
1.35
7.53
0.66
0.58
1.08
0.53
29.68
Current Assets
3,632.20
3,762.40
3,509.19
2,952.50
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,289.60
1,380.50
1,254.87
1,129.38
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
Sundry Debtors
915.90
961.20
927.99
819.90
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
Cash & Bank
956.80
1,014.30
984.24
671.32
1,399.87
1,370.41
248.79
459.63
344.58
394.34
Other Current Assets
469.90
135.10
110.93
242.37
499.88
525.44
418.81
262.79
377.13
265.59
Short Term Loans & Adv.
228.00
271.30
231.17
89.53
80.29
39.80
45.75
37.06
133.06
144.56
Net Current Assets
1,743.20
1,990.00
1,917.59
1,903.67
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
Total Assets
11,071.90
10,929.20
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
971.30
660.70
837.54
1,784.27
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
PBT
170.50
27.80
630.45
1,212.01
1,210.53
903.81
859.08
737.64
542.22
40.32
Adjustment
755.40
782.90
579.47
716.48
760.74
861.53
687.81
637.90
737.89
725.84
Changes in Working Capital
253.10
54.30
-178.29
249.90
-179.67
-300.53
14.15
36.88
-133.16
96.40
Cash after chg. in Working capital
1,179.00
865.00
1,031.63
2,178.39
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-207.70
-204.30
-194.09
-394.12
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-607.90
-544.40
-380.37
-739.01
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
Net Fixed Assets
-51.10
-92.16
-752.97
2,198.22
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
Net Investments
-0.30
-10.85
0.23
118.05
-0.14
-57.59
3.34
-0.39
57.01
239.81
Others
-556.50
-441.39
372.37
-3,055.28
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
Cash from Financing Activity
-432.50
-156.70
-32.60
-1,709.39
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
Net Cash Inflow / Outflow
-69.10
-40.40
424.57
-664.13
165.56
767.10
-215.63
132.22
-56.38
-62.76
Opening Cash & Equivalents
1,013.90
983.80
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.64
473.49
Closing Cash & Equivalent
956.40
1,013.90
983.82
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.63

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
343.00
339.19
333.91
297.84
351.83
301.93
262.33
220.61
190.90
154.04
ROA
0.65%
-0.63%
4.44%
5.34%
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
ROE
1.34%
-1.21%
8.21%
10.88%
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
ROCE
5.02%
2.53%
9.97%
11.89%
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
Fixed Asset Turnover
0.88
0.89
0.95
0.87
1.23
1.38
1.26
1.09
0.92
0.81
Receivable days
51.11
54.89
52.04
63.24
51.13
48.12
51.58
59.43
54.81
49.56
Inventory Days
72.70
76.56
70.98
89.02
65.05
56.26
63.07
73.64
75.51
78.58
Payable days
143.02
134.99
133.47
191.38
58.75
55.42
56.86
54.84
53.44
52.17
Cash Conversion Cycle
-19.21
-3.54
-10.45
-39.12
57.43
48.96
57.79
78.23
76.88
75.98
Total Debt/Equity
0.63
0.63
0.55
0.55
0.83
1.01
0.85
1.18
1.51
1.95
Interest Cover
1.63
1.15
5.33
5.67
5.21
5.11
4.02
3.16
2.46
1.11

News Update:


  • Jubilant Pharmova - Quarterly Results
    25th Oct 2024, 12:26 PM

    Read More
  • Jubilant Pharmova’s arm gets VAI classification for USA manufacturing facility
    10th Sep 2024, 16:28 PM

    USFDA had conducted an inspection at said facility from May 28, 2024 to June 6, 2024

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.